Skip to main content
Vitrolife logo

Vitrolife — Investor Relations & Filings

Ticker · VITR ISIN · SE0011205202 LEI · 5493001WDZMONMSPPR49 ST Manufacturing
Open in API
Filings indexed 654 across all filing types
Latest filing 2026-05-05 Regulatory Filings
Country SE Sweden
Listing ST VITR

About Vitrolife

https://www.vitrolife.com/

Vitrolife is a global company focused on reproductive health, providing medical devices and genetic testing services primarily to In Vitro Fertilization (IVF) clinics. The company develops, produces, and markets a comprehensive portfolio of products and solutions that support the entire assisted reproduction treatment journey, from oocyte retrieval and sperm preparation to fertilization, embryo culture, evaluation, transfer, and cryopreservation. With a strong emphasis on quality control, innovation, and clinical support, Vitrolife aims to improve treatment outcomes and operational efficiency for its partners. The company also offers educational resources and training for professionals through its Vitrolife Academy.

Recent filings

Filing Released Lang Actions
Kommuniké från årsstämma i Vitrolife AB (publ)
Regulatory Filings
2026-05-05 English
Report from the Annual General Meeting of Vitrolife AB (publ)
Regulatory Filings
2026-05-05 English
Kallelse till årsstämman i Vitrolife AB (publ)
Proxy Solicitation & Information Statement Classification · 91% confidence The document is a formal notice (kallelse) for the 2026 Annual General Meeting of Vitrolife AB, detailing registration procedures, agenda items, board and nomination committee proposals, voting instructions, and proxy (poströstning) forms. It is distributed to shareholders to provide comprehensive meeting information and solicit votes. This corresponds to Proxy Solicitation & Information Statement rather than the actual AGM presentation or a post-meeting voting result. Therefore, the correct classification is PSI.
2026-04-01 Swedish
Notice of the Annual General Meeting of Vitrolife AB (publ)
Proxy Solicitation & Information Statement Classification · 85% confidence The document is the "Notice of the Annual General Meeting" of Vitrolife AB, detailing the date, time, registration, agenda items, proposals by the Nomination Committee and Board, dividend proposal, share incentive plan, authorisations for share issues and buybacks, proxy and postal voting instructions. This is a materials package sent to shareholders ahead of the AGM to provide information and solicit votes (including proxy voting). Thus it fits the "Proxy Solicitation & Information Statement" category (Code: PSI).
2026-04-01 English
The Nomination Committee proposes two new Board members
Board/Management Information Classification · 94% confidence The document is a press release from Vitrolife AB announcing the Nomination Committee’s proposal to elect two new Board members and re-elect certain directors at the upcoming Annual General Meeting. It is an announcement of changes in the board of directors rather than the full AGM materials or an annual report. According to the definitions, this falls under Board/Management Information (MANG).
2026-04-01 English
Valberedningen föreslår två nya styrelseledamöter
Board/Management Information Classification · 95% confidence The document is a corporate announcement by Vitrolife AB stating that its nominations committee (valberedningen) proposes the election and re-election of members to the company’s board of directors ahead of the 2026 annual general meeting. This is clearly an announcement of changes in the board of directors, matching the definition for 'Board/Management Information' (MANG).
2026-04-01 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.